<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-31T06:21:20Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/39930" metadataPrefix="rdf">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/39930</identifier><datestamp>2026-02-03T11:11:46Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37953</setSpec></header><metadata><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:riuma.uma.es:10630/39930">
      <dc:title>Alteration of IGF-1 bioavailability due to PAPPA2 deficiency leads to sex-specific metabolic disturbances</dc:title>
      <dc:creator>López-Gambero, Antonio J.</dc:creator>
      <dc:creator>Vargas, Antonio</dc:creator>
      <dc:creator>Fernández-Arjona, María del Mar</dc:creator>
      <dc:creator>Rubio-Lamia, Leticia Olga</dc:creator>
      <dc:creator>De Ceglia, Marialuisa</dc:creator>
      <dc:creator>Vera-Fernández, Carlos</dc:creator>
      <dc:creator>Campillo-Calatayud, Ana</dc:creator>
      <dc:creator>Rivera-González, Patricia</dc:creator>
      <dc:creator>Rodriguez-de-Fonseca, Fernando</dc:creator>
      <dc:creator>Barrios, Vicente</dc:creator>
      <dc:creator>Chowen, Julie A.</dc:creator>
      <dc:creator>Argente, Jesús</dc:creator>
      <dc:creator>Suárez-Pérez, Juan</dc:creator>
      <dc:subject>Endocrinología</dc:subject>
      <dc:subject>Metabolismo - Aspectos endocrinos</dc:subject>
      <dc:subject>Hormonas</dc:subject>
      <dc:subject>Diferencias sexuales</dc:subject>
      <dc:subject>Homeostasis</dc:subject>
      <dc:description>Background: The growth hormone (GH)/insulin-like growth factor (IGF-1) axis determines optimal growth and&#xd;
affects metabolism and energy homeostasis. Pregnancy-associated plasma protein-A2 (PAPPA2) regulates&#xd;
bioactive IGF-1 availability and patients with PAPPA2 deficiency have impaired growth and glucose metabolism. This axis is altered in metabolic disturbances such as obesity and anorexia nervosa in a sex-specific manner, but the mechanisms involved are not completely understood. Here we evaluated how Pappa2 deficiency affects energy homeostasis, focusing on male and female differences.&#xd;
Methods: Growth and energy homeostasis were determined in male and female Pappa2ko/ko mice and control&#xd;
Pappa2wt/wt littermates, as well as their response to recombinant human (rh)PAPPA2, rhIGF-1 and rhIBFBP5.&#xd;
Effects of a high-carbohydrate diet (HCHD) on glucose tolerance, fuel partitioning, de novo lipogenesis and&#xd;
energy homeostasis were determined.&#xd;
Results: Pappa2ko/ko mice had reduced body weight, bone length and lipid deposition associated with higher&#xd;
energy expenditure and intake. Male Pappa2ko/ko mice had mild glucose intolerance, altered bone mineral&#xd;
properties and higher energy costs for locomotor activity possibly due to inefficient muscle mitochondrial activity; whereas female Pappa2ko/ko mice had enhanced fatty acid oxidation on a normal diet, but not on a HCHD. All Pappa2ko/ko mice had lower hepatic fat deposition associated with lower IGF-1 activity in the liver, while fatty acid metabolism dysregulation in adipose tissue was found only in females.&#xd;
Conclusion: These data reinforce the importance of the GH/IGF-1 axis in metabolic control and emphasize the&#xd;
relevance of its fine-tuned control by Pappa2. Moreover, the differences between sexes in metabolic imbalances underscore the relevance of sex-specific strategies for treatment of metabolic imbalances.</dc:description>
      <dc:date>2025-09-16T08:55:40Z</dc:date>
      <dc:date>2025-09-16T08:55:40Z</dc:date>
      <dc:date>2025-10</dc:date>
      <dc:type>journal article</dc:type>
      <dc:identifier>Antonio J. López-Gambero, Antonio Vargas, María del Mar Fernández-Arjona, Leticia Rubio, Marialuisa de Ceglia, Carlos Vera-Fernández, Ana Campillo-Calatayud, Patricia Rivera, Fernando Rodríguez de Fonseca, Vicente Barrios, Julie A. Chowen, Jesús Argente, Juan Suárez, Alteration of IGF-1 bioavailability due to PAPPA2 deficiency leads to sex-specific metabolic disturbances, Metabolism, Volume 171, 2025, 156355, ISSN 0026-0495, https://doi.org/10.1016/j.metabol.2025.156355. (https://www.sciencedirect.com/science/article/pii/S0026049525002240)</dc:identifier>
      <dc:identifier>https://hdl.handle.net/10630/39930</dc:identifier>
      <dc:identifier>10.1016/j.metabol.2025.156355</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
      <dc:rights>open access</dc:rights>
      <dc:rights>Atribución 4.0 Internacional</dc:rights>
      <dc:publisher>ELSEVIER</dc:publisher>
   </ow:Publication>
</rdf:RDF>
</metadata></record></GetRecord></OAI-PMH>